Nicotine Dependence
📧 Sign up to get email alerts when something new happens for Nicotine Dependence.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-07-10Clinical Trial Update: Cumulative Skin Irritation Potential of a New 25 mg Nicotine Patch [Phase 1]
Phase 1 study evaluating the cumulative skin irritation potential of a new 25 mg nicotine patch for smoking cessation.
-
CLINICAL_TRIALS trial_result · 2012-07-10Clinical Trial Update: Pilot Study of a New Nicotine Replacement Therapy [Phase 2]
Phase 2 pilot study of a new nicotine replacement therapy for smoking cessation has completed.
-
CLINICAL_TRIALS trial_result · 2012-07-04Clinical Trial Update: Testing Counseling Styles to Motivate Smokers to Quit [Phase 3]
Phase 3 trial evaluating counseling styles to motivate smokers to quit. The study is completed.
-
CLINICAL_TRIALS trial_result · 2012-06-27Clinical Trial Update: Smoking Treatment in HIV Clinical Care Settings [Phase 3]
A Phase 3 trial evaluating a smoking cessation treatment in HIV clinical care settings has completed, focusing on nicotine dependence.
-
CLINICAL_TRIALS other · 2012-06-20Clinical Trial Update: Cue Reactivity in Virtual Reality: The Role of Context
The clinical trial at M.D. Anderson Cancer Center investigating cue reactivity in virtual reality for nicotine dependence has been terminate…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-06-01Clinical Trial Update: Medications Development for the Treatment of Cannabis Related Disorders [Phase 1]
Phase 1 clinical trial update from the University of Virginia evaluating medications for cannabis-related disorders; the study status is com…
-
FDA approval · 2012-05-23FDA Approved: NICORETTE — Supplemental Application (Haleon US Holdings LLC)
The FDA approved a supplemental application for NICORETTE (nicotine polacrilex) from Haleon US Holdings LLC.
-
CLINICAL_TRIALS trial_result · 2012-05-14Clinical Trial Update: A Follow-up Study to Assess Long-term Immunogenicity and Safety of NicVAX/Placebo as an Aid to Smoking Cessation
A follow-up study evaluating long-term immunogenicity and safety of NicVAX versus placebo as an aid to smoking cessation has been completed.…
-
CLINICAL_TRIALS trial_result · 2012-05-14Clinical Trial Update: A Comparability Study of the Phase 3 Lot and a Single Commercial Lot of NicVAX in Healthy Adult Smokers [Phase 3]
This update reports a comparability study comparing the Phase 3 production lot and a single commercial lot of NicVAX in healthy adult smoker…
-
CLINICAL_TRIALS trial_result · 2012-05-09Clinical Trial Update: Antibody and Safety Study of 6 Doses of NicVAX in Smokers [Phase 1, Phase 2]
A Phase 1/2 clinical trial update reports completion of a study evaluating six doses of NicVAX, Nabi Biopharmaceuticals' nicotine vaccine, i…
-
CLINICAL_TRIALS trial_result · 2012-05-09Clinical Trial Update: NicVAX/Placebo as an Aid for Smoking Cessation [Phase 3]
Phase 3 trial evaluating NicVAX (vaccine) vs placebo for smoking cessation has completed.
-
CLINICAL_TRIALS research · 2012-05-09Clinical Trial Update: Pharmacoeconomic Assessment in Nabi-4514 and Nabi-4515 Phase 3 Studies [Phase 3]
This document reports pharmacoeconomic analyses for Nabi-4514 and Nabi-4515 in Phase 3 smoking cessation trials.
-
CLINICAL_TRIALS research · 2012-05-02Clinical Trial Update: Effects of Intensive Behavioral Training Program on Impulsivity and Inhibitory Control in Smokers [NA]
This clinical trial update describes a study evaluating whether an intensive behavioral training program can reduce impulsivity and improve …
-
FDA approval · 2012-04-25FDA Approved: FOSTER AND THRIVE NICOTINE — Supplemental Application (Strategic Sourcing Services LLC)
FDA approved a supplemental application for Foster and Thrive Nicotine (nicotine polacrilex) submitted by Strategic Sourcing Services LLC.
-
CLINICAL_TRIALS trial_result · 2012-04-25Clinical Trial Update: Smoking Reduction or Cessation With Nicotine Replacement Therapy [Phase 3]
Phase 3 trial update reports completion of a study evaluating nicotine replacement therapy for smoking cessation. The snippet does not speci…
-
FDA approval · 2012-04-23FDA Approved: BUPROPION HYDROCHLORIDE SR — Supplemental Application (Actavis Pharma, Inc.)
FDA approves a supplemental application for Bupropion HCl sustained-release (Actavis), finalizing changes to the approved generic product.
-
FDA approval · 2012-04-19FDA Approved: BASIC CARE NICOTINE — Supplemental Application (Amazon.com Services LLC)
The FDA approved a supplemental application for Basic Care Nicotine (nicotine polacrillex) from Amazon.com Services LLC, updating its regula…
-
FDA approval · 2012-04-18FDA Approved: BUPROPION HYDROCHLORIDE SR — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Bupropion Hydrochloride SR from Actavis Pharma, Inc.
-
CLINICAL_TRIALS trial_result · 2012-04-13Clinical Trial Update: Smoking Cessation in Alcoholics [NA]
A completed clinical trial studying smoking cessation in individuals with alcohol use issues has posted its results.
-
CLINICAL_TRIALS trial_result · 2012-04-11Clinical Trial Update: The Effect of Cycloserine on Smoking Behavior in Nicotine Dependent Smokers [NA]
This completed clinical trial evaluated whether cycloserine affects smoking behavior in nicotine-dependent individuals. Results were posted …
-
CLINICAL_TRIALS trial_result · 2012-04-09Clinical Trial Update: Efficacy of Varenicline in Methadone-Stabilized Cocaine Users [NA]
Clinical trial update on the efficacy of varenicline in methadone-stabilized cocaine users; results posted after completion.
-
FDA approval · 2012-03-28FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Apnar Pharma LP)
FDA approved a supplemental application for Bupropion Hydrochloride from Apnar Pharma LP, confirming approval of a generic formulation.
-
FDA approval · 2012-02-21FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved Amneal Pharmaceuticals of New York LLC's supplemental application for bupropion hydrochloride (generic), confirming approval fo…
-
CLINICAL_TRIALS trial_result · 2012-02-17Clinical Trial Update: Efficacy and Safety of Dianicline Treatment as an Aid to Smoking Cessation in Cigarette Smokers (AMERIDIAN) [Phase 3]
Phase 3 trial updates the efficacy and safety of dianicline as an aid to smoking cessation in cigarette smokers; study status is completed.
-
FDA approval · 2012-02-15FDA Approved: NICORETTE 4MG FRUIT CHILL GUM, LIL DRUG STORE — Supplemental Application (Lil' Drug Store Products, Inc.)
FDA approved a supplemental application for NICORETTE 4MG FRUIT CHILL GUM (nicotine polacrilex) from Lil' Drug Store Products, expanding nic…